Fritextsökning
Innehållstyper
-
Astra Zeneca’s Sweden CEO: “We have great faith in our portfolio”
It all started with a summer job as an operator at Astra’s chemical factory in Snäckviken, just outside Södertälje. More than three decades and countless differ...
-
The Top 10 Challenges Facing Laboratories Today
Navigating the Laboratory Automation Landscape
-
Branschkritik mot EU:s nya läkemedelsförslag – ”En försämring”
”Som helhet en försämring”. ”En förlorad möjlighet”. Så reagerar svenska och europeiska branschorganisationer på kompromissen om en ny läkemedelslagstiftning i EU.
-
Webinar: Can AI replace humans in pharmacovigilance?
The webinar will explore how AI can transform pharmacovigilance by enhancing efficiency, reducing errors, and addressing challenges such as software costs, data...
-
“Don’t postpone the transition to IVDR”
Operators who have not yet started to adapt to the requirements of the new EU IVDR regulation are running out of excuses. This is the opinion of Helena Dzojic, ...
-
Large study: The benefits and risks of obesity medications
Medications such as Ozempic can reduce the risk of a range of different diseases and health conditions but also increase the risk of others. This is according t...
-
Cost-efficient development of laboratory devices
8 ways to optimise development costs and speed up processes
-
Revealing the secrets of a part
CT inspection in automation technology at Festo.
-
US Health Secretary Kennedy dismisses all vaccine experts – assembles new committee
Robert F. Kennedy Jr. has dismissed all 17 members of the CDC’s vaccine advisory panel. A new group of experts will be appointed directly by the Health Secretar...
-
Rapport: Två av tre biotechbolag med AI-satsning ser bättre resultat
Företag inom life science ligger i framkant när det gäller att använda AI – både i bredd och mognad. Två av tre biotechbolag som satsar strategiskt på tekniken ...
-
Forskaren in Hagastaden now inagurated
The real estate company Vectura's life science center in Hagastaden, Forskaren, is now inaugurated. The opening was attended by people from the industry, politi...
-
Gallagher – din försäkringsrådgivare inom Life Science
Med över 25 års erfarenhet av att leverera försäkring- & riskhanteringstjänster till life science-sektorn är vi på Gallagher ledande på området i Sverige. Som e...
-
Precision and accuracy in liquid handling
How to evaluate and optimize liquid handling performance
-
Large study on milk: Risky for women but not for men
The risk of ischemic heart disease (IHD) and acute myocardial infarction (MI) increased for women with milk intake levels higher than 2 glasses per day, while n...
-
A new scientific event in Gothenburg
Life Science Sweden is holding an event in Gothenburg for the first time.
-
Life science trends 2025 – Part 1 obesity drugs
More obesity drugs are being launched this year following Novo Nordisk and Eli Lilly's previous successes with GLP-1 drugs. But the next big breakthrough in obe...
-
It couldn’t be simpler
AI-assisted ZEISS Solution inspects implant coatings automatically.
-
The investor: “The major common diseases are hot again”
She has previously been voted Investor of the Year and will now be moderating The Future of Swedish & Danish Life Science congress. We check the temperature of ...
-
Bayer i miljardavtal om ny cancerkandidat – medan en annan partner lägger ner
Tyska Bayer har tecknat ett avtal med mångmiljardpotential med Kumquat Sciences om utveckling av ett nytt cancerläkemedel. Samtidigt meddelas att en annan av Ba...
-
Nya patent stärker Alzecures globala skydd
Forskningsbolaget Alzecure Pharma har beviljats nya patent i Kina, Indien och fyra andra länder för Alzheimerskandidaten ACD856.
-
Drug development booms in Medicon Valley
When it comes to developing new medicines, the Öresund region is one of the top performers in the EU. Companies working on commission for pharmaceutical compani...
-
Investigations against AstraZeneca: ”Chinese interests may be behind them”
Why are there several investigations against AstraZeneca employees in China right now? Life Science Sweden continues to seek answers.
-
Eli Lilly requests re-examination of Alzheimer's drug recommendation
Eli Lilly has requested that the EMA re-examine its opinion on the company's Alzheimer's drug, Kisunla, the agency announced on Friday.
-
Anna Törner: ”If I fall seriously ill, I’ll move to Finland”
”It is both undignified and undemocratic that cancer patients must travel to Finland to uphold a façade of fairness that does not truly exist”, Anna Törner writes in a column.
BREAKING